ARQT Arcutis Biotherapeutics, Inc.

NASDAQ
$25.08

Arcutis Biotherapeutics, Inc. (ARQT) Institutional Ownership

What the institutions did with ARQT last quarter, from their 13F filings. Counting managers rather than shares is the point: a single index fund adding to a position tells you far less than four hundred separate managers all deciding to. Positions as reported for the quarter ended June 30, 2026.

Managers reporting
304
filed a 13F this quarter
Managers holding
268
+3 on the quarter
Buyers
134
39 opened new
Sellers
135
36 sold out entirely
Buyer share
49.8%
of managers who traded it
Breadth
-0.4
net buyers, as a share of those trading

Every manager below opens. Subscribers can see any firm's whole portfolio — every position, its weight, and what they bought, trimmed and exited last quarter.

Sign in or subscribe

Largest holders

Manager Shares % of reported
MONTANOVA CAPITAL, LLC 12.4M 9.5%
BlackRock, Inc. 10.5M 8.0%
Frazier Life Sciences Management, L.P. 9.9M 7.5%
Rubric Capital Management LP 8.3M 6.3%
Polar Capital Holdings Plc 6.6M 5.0%
STATE STREET CORP 5.8M 4.4%
VANGUARD CAPITAL MANAGEMENT LLC 5.0M 3.8%
MORGAN STANLEY 4.5M 3.4%
JENNISON ASSOCIATES LLC 4.2M 3.2%
D. E. Shaw & Co., Inc. 3.9M 3.0%
UBS Group AG 3.3M 2.5%
BANK OF AMERICA CORP /DE/ 3.0M 2.3%
GEODE CAPITAL MANAGEMENT, LLC 3.0M 2.3%
VANGUARD PORTFOLIO MANAGEMENT LLC 2.4M 1.8%
ORBIMED ADVISORS LLC 2.0M 1.6%
FRANKLIN RESOURCES INC 1.9M 1.5%
AMERICAN CENTURY COMPANIES INC 1.9M 1.5%
GOLDMAN SACHS GROUP INC 1.7M 1.3%
Jupiter Topco LLC 1.4M 1.1%
OBERWEIS ASSET MANAGEMENT INC/ 1.4M 1.0%
GILDER GAGNON HOWE & CO LLC 1.3M 1.0%
GW&K Investment Management, LLC 1.3M 1.0%
Pivotal bioVenture Partners Investment Advisor LLC 1.3M 1.0%
BAMCO INC /NY/ 1.3M 1.0%
CITADEL ADVISORS LLC 1.2M 0.9%

Largest changes

Manager Action Previous Current Change
GILDER GAGNON HOWE & CO LLC Reduced 4.3M 1.3M -3.0M
ORBIMED ADVISORS LLC New 0 2.0M +2.0M
MARSHALL WACE, LLP Reduced 2.4M 446.9K -2.0M
D. E. Shaw & Co., Inc. Increased 2.5M 3.9M +1.5M
Driehaus Capital Management LLC Reduced 2.2M 878.4K -1.3M
BlackRock, Inc. Increased 9.2M 10.5M +1.3M
CITADEL ADVISORS LLC Increased 15.6K 1.2M +1.1M
Jones Hill Capital LP New 0 1.1M +1.1M
Polar Capital Holdings Plc Increased 5.7M 6.6M +940.0K
BANK OF AMERICA CORP /DE/ Increased 2.2M 3.0M +766.1K
JENNISON ASSOCIATES LLC Reduced 5.0M 4.2M -761.7K
MPM BIOIMPACT LLC Sold Out 734.0K 0 -734.0K
STEMPOINT CAPITAL LP Reduced 827.6K 98.9K -728.6K
Squarepoint Ops LLC Reduced 1.1M 537.7K -565.7K
MILLENNIUM MANAGEMENT LLC Increased 49.3K 564.1K +514.7K
VANGUARD PORTFOLIO MANAGEMENT LLC Increased 2.0M 2.4M +474.3K
STATE STREET CORP Reduced 6.3M 5.8M -473.4K
M&G PLC Sold Out 469.1K 0 -469.1K
AMERICAN CENTURY COMPANIES INC Increased 1.5M 1.9M +461.8K
Aberdeen Group plc Increased 645.1K 1.1M +453.3K
Eversept Partners, LP Reduced 576.6K 135.4K -441.2K
TWO SIGMA INVESTMENTS, LP Increased 234.3K 663.9K +429.6K
VOLORIDGE INVESTMENT MANAGEMENT, LLC Reduced 540.5K 157.4K -383.1K
RENAISSANCE TECHNOLOGIES LLC Reduced 441.0K 58.4K -382.6K
FRANKLIN RESOURCES INC Reduced 2.3M 1.9M -367.0K

13F filings are due 45 days after quarter end and cover long positions in U.S.-listed equities only, so this is a lagged and partial picture: shorts, bonds and foreign listings never appear. Options positions are excluded here rather than folded into the share counts. Political ownership is coming.